KPIs & Operating Metrics(New)
Growth Metrics

Chemed (CHE) Receivables (2016 - 2026)

Chemed filings provide 18 years of Receivables readings, the most recent being $215.5 million for Q1 2026.

  • For the quarter ending Q1 2026, Receivables fell 25.03% year-over-year to $215.5 million, compared with a TTM value of $215.5 million through Mar 2026, down 25.03%, and an annual FY2025 reading of $191.2 million, up 6.26% over the prior year.
  • Receivables hit $215.5 million in Q1 2026 for Chemed, up from $191.2 million in the prior quarter.
  • The five-year high for Receivables was $287.4 million in Q1 2025, with the low at $117.3 million in Q1 2022.
  • Median Receivables over the past 5 years was $180.0 million (2024), compared with a mean of $176.3 million.
  • The sharpest move saw Receivables skyrocketed 60.22% in 2025, then dropped 25.03% in 2026.
  • Year by year, Receivables stood at $141.2 million in 2022, then increased by 29.7% to $183.2 million in 2023, then fell by 1.76% to $180.0 million in 2024, then increased by 6.26% to $191.2 million in 2025, then grew by 12.68% to $215.5 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $215.5 million, $191.2 million, and $223.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.